Impact of maintenance therapy on subsequent treatment in patients with newly diagnosed multiple myeloma: use of "progression-free survival 2" as a clinical trial end-point / Dimopoulos, Ma; Petrucci, Mt; Foa, Roberto; Catalano, J; Kropff, M; Terpos, E; Zhang, J; Grote, L; Jacques, C; Palumbo, A.. - In: HAEMATOLOGICA. - ISSN 0390-6078. - (In corso di stampa). [10.3324/haematol.2014.120790]
Impact of maintenance therapy on subsequent treatment in patients with newly diagnosed multiple myeloma: use of "progression-free survival 2" as a clinical trial end-point.
FOA, Roberto;
In corso di stampa
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
